|
Administration Core |
1P01AG073090-01A1 |
|
NIA |
2022 |
|
Parenchymal border macrophages in AD and CAA |
1P01AG078106-01 |
|
NIA |
2022 |
|
Interplay between meningeal lymphatics, high-density lipoproteins and border macrophages in cerebral amyloid angiopathy |
1P01AG078106-01 |
|
NIA |
2022 |
|
Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics |
1P01AG078106-01 |
|
NIA |
2022 |
|
Project 3 - Astrocytic glutamate dysregulation in AD and VCID |
1P01AG078116-01 |
|
NIA |
2022 |
|
Project 2 - Astrocytic insulin signaling and AD |
1P01AG078116-01 |
|
NIA |
2022 |
|
Assessment of Language and Cognition in Older Deaf Signers |
1R01AG074928-01 |
|
NIA |
2022 |
|
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD |
1R01AG075404-01A1 |
|
NIA |
2022 |
|
Language Switching with Alzheimers Disease |
1R01AG076415-01 |
|
NIA |
2022 |
|
NIA/AA for Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (NIA/AA IMPACT-AD Course) |
1R25AG076392-01 |
|
NIA |
2022 |